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Introduction {#sec1}
============

Cellular decision-making often relies on the output of its gene regulatory networks, which are sensitive to intra- and extracellular signals ([@bib4], [@bib32]). In some cases, the gene network senses and responds to these signals by up- or downregulating the expression levels of certain genes to optimize the organism\'s survival ([@bib24]). In other cases, however, it is preferable for the cell\'s phenotype to remain insensitive (robust) to perturbations ([@bib2], [@bib47], [@bib50]). There are a great variety of perturbations that gene networks must mitigate, such as changes in physical conditions (e.g., temperature), the abundance of environmental toxins or nutrients, and the fluctuation of intracellular protein and toxin levels. In particular, one such perturbation to gene networks is DNA copy number fluctuation (e.g., by DNA replication), which virtually all living organisms must experience. Gene copy number changes can potentially affect gene expression to cause significant phenotypic changes ([@bib5], [@bib21], [@bib33], [@bib38], [@bib43]). For example, highly amplified genes in cancer cells often show elevated expression ([@bib33]), whereas inactivation of a single allele in diploid organisms can reduce expression and lead to diseases ([@bib43]). Theoretical modeling also reveals that a number of commonly observed gene regulatory subnetworks, or network motifs, are sensitive to gene copy number changes due to interactions via a common pool of transcription factors in the duplicated networks ([@bib28]).

Organisms can also develop strategies to deal with gene dosage changes and their cognate effects. A recent study reveals that in budding yeast, *Saccharomyces cerevisiae*, the expression of a large fraction of genes is significantly reduced when the gene dosage is halved, whereas some genes have unaltered expression ([@bib46]). This suggests that there may exist mechanisms and control structures keeping a small number of genes robust to gene dosage variations. Indeed, some studies have reported network structures allowing gene expression insensitivity to DNA dosage changes ([@bib1], [@bib44]). However, those observations are most often based on gene deletions or insertions, and the effects of replication-associated temporal DNA copy number changes remain largely unknown. Given the prevalence of DNA replication and the fluctuation of DNA levels during cell growth, it is natural to ask how gene networks can cope with or take advantage of DNA replication to choose the optimal cell fate.

To understand the effect of DNA copy number fluctuations on gene expression and network level outputs, we use phage lambda as a model system to study how ongoing viral replication affects the lysis-lysogeny decision. The genetic components involved in this lysis-lysogeny decision have been well-characterized ([@bib14], [@bib30], [@bib35]). The default lytic pathway for lambda infection is executed by the transcription and translation of the lysis and phage morphological genes, which lead to the bursting of the cell and release of hundreds of phage progeny. These events are triggered when the anti-terminator protein, Q, reaches a threshold, allowing transcription from promoter pR′ to bypass the downstream terminator, tR′ ([@bib9], [@bib22], [@bib40]). The alternative lysogenic pathway culminates in the integration of phage DNA into the *E. coli* chromosome, and the inhibition of gene transcription from the two major promoters pR and pL by repressor CI ([@bib30]). The master viral regulator, CII, plays a central role in controlling CI production by activating the pRE promoter. The choice between lytic and lysogenic development is therefore shaped by the cascade of regulatory genes expressed early in the infection process. After a decision is made, it is enforced by CI to establish the lysogenic pathway, or by cell destruction through lysis to complete the lytic pathway. Phage DNA replication starts shortly after the infection, causing a radical change in DNA copy number concordant with the expression of lysis-lysogeny decision-making genes. Here, we examine the effect of gene dosage change on the expression of two highly important decision regulators, CII and CI.

An alternative source of DNA copy number variation in the lambda infection system is the different MOI (Multiplicity of Infection, or number of infecting phages per cell), which determines the initial concentration of intracellular phage DNA. Current experimental evidence and theoretical models of phage lambda suggest that lysogenization is preferred at a higher MOI, i.e., higher initial DNA concentration ([@bib9], [@bib18], [@bib23], [@bib51], [@bib52]). A deterministic model of the CI/Cro bistable switch predicts that a high CI, low Cro state becomes the dominant attractor state when viral concentration is high ([@bib51]) because higher MOI leads to a higher transient spike in CII levels, causing an overshoot of CI via CII activation of the pRE promoter. This allows the CI/Cro bistable switch to flip to the direction of high CI and low Cro levels even if Cro was initially high, consistent with the lysogenic development ([@bib22]). A quasi-stochastic version of this model indicated that this trend holds true even if lytic and lysogenic decisions are determined by threshold crossing of Q and CI, respectively, as opposed to steady state attractors ([@bib18]). Notably, these two models kept the viral DNA level constant throughout the dynamics by leaving out DNA replication, and just varied the infection MOI. Later, DNA replication was introduced in other models, which suggests that DNA replication promotes lysogeny by increasing DNA concentration similar to higher MOI ([@bib9], [@bib39]). However, thorough experimental interrogation of the regulation of decision-making by DNA replication is still lacking.

In this work, we experimentally characterize the role of DNA replication in the lysis-lysogeny decision of lambda phage and discover that CII levels remain robust to DNA replication, especially during the early infection period. Combined with mathematical modeling, our work suggests that negative feedback by Cro plays an important role in keeping CII expression robust to DNA replication. On the contrary, expression of *cI*, the downstream target gene of *cII*, is extremely sensitive to DNA copy number variations, thereby affecting the lysis-lysogeny decisions. Overall, we show that different elements of a gene network respond distinctly to copy number variations and demonstrate the potential of negative feedback regulation to encode phenotypic robustness against extremely variable DNA copy numbers.

Results {#sec2}
=======

Lack of DNA Replication Leads to Failure in Lytic and Lysogenic Development {#sec2.1}
---------------------------------------------------------------------------

To understand how DNA replication may affect the lysis-lysogeny decision, we studied phage infection outcomes in the absence of replication. For this, we investigated how the DNA replication-defective λ*P*^*-*^ mutant (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} and [Tables S1--S4](#mmc1){ref-type="supplementary-material"} for more strain information) differs in its ability to make decisions compared with the wild-type (WT) laboratory strain λWT. The lysogenization frequency of λ*P*^*-*^ has been reported ([@bib23]) to be lower than that of λWT at low APIs (average phage input, calculated as plaque-forming unit \[PFU\]/colony-forming unit \[CFU\]). We confirmed this earlier finding ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In addition, the lysogenic response (percentage of lysogeny) of λ*P*^*-*^ phage to API follows a Poisson distribution of n ≥ 3, indicating that lysogenization requires 3 or more λ*P*^*-*^ phages on average, compared with n ≥ 2 for λWT ([Figure S1](#mmc1){ref-type="supplementary-material"}B). This suggests that lysogenic decisions are possible in the absence of DNA replication, but more initial phage inputs are required to cause the same level of lysogenization.

To quantitatively detect the differences in decision-making behaviors in the presence and absence of phage DNA replication, we utilized our established lytic-lysogenic reporter systems ([@bib49]) to study the decision-making of λ*P*^*-*^ phage at the single-cell/single-phage level. Briefly, a fluorescent protein (mKO2) is inserted downstream of *cI* on the phage genome to report *cI* transcription activity, corresponding to lysogenic events by λWT infections ([Figures 1](#fig1){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}). Another fluorescent protein (mTurquoise2) was fused to the C terminus of the phage capsid decoration protein, gpD. Thus, mTurquoise2 fluorescence reports lytic development up until host cell lysis for λWT infections ([Figure 1](#fig1){ref-type="fig"}A). This method also allows the quantification of MOI for each infection ([Figure 1](#fig1){ref-type="fig"}A, blue dot at 0 min). Overall, the λ*P*^*-*^ phage lysogenized less frequently than λWT ([Figure 1](#fig1){ref-type="fig"}C), as predicted by bulk experiments ([Figure S1](#mmc1){ref-type="supplementary-material"}). Remarkably, λ*P*^*-*^ phage infections showed no lysogenic events at MOI = 1 ([Figure 1](#fig1){ref-type="fig"}C, 0 of 35 cells). In the lysogenic cells of MOI \> 1, the *cI* reporter signal was lower than in λWT infections ([Figures 1](#fig1){ref-type="fig"}A and 1B), suggesting that *cI* transcription levels are lower in the absence of DNA replication. In addition, DNA replication is also required for cell lysis, as we only observed very low levels of the lytic reporter expression ([Figure 1](#fig1){ref-type="fig"}B). Accordingly, lysis did not occur within the time window of our time-lapse movies (4 hr) as opposed to λWT, where cells lysed at 114 ± 16 min (mean ± SD, N = 243). Overall, our data suggest that the decision-making network outputs, CI and the lysis genes, are severely compromised in the absence of DNA replication. The expression of these genes is regulated by their corresponding transcription factors, CII and Q, respectively. Therefore, we next sought to quantify how DNA replication affects the expression of these transcription factors from the pR promoter using single-molecule fluorescence *in situ* hybridization (smFISH).Figure 1More than One Copy of Phage DNA Is Required for Lysogenic Establishment(A) Representative images showing lytic and lysogenic events by λWT. Top: a cell is apparently infected by one λWT phage (blue dot at 0 min), and subsequently gpD-mTurquoise2 expression (blue) is observed. Cell lysis is observed at 195 min. Bottom: a cell is apparently infected by one λWT phage (blue dot at 0 min). *cI* reporter expression (yellow) and cell division are observed, indicating a successful lysogenization event.(B) Representative images of lysogenic and failed infection by λ*P*^*-*^. Top: a cell is apparently infected by 3 λ*P*^*-*^ phages (blue dots at 0 min). The cell divides, and expression of the *cI* reporter (yellow) is observed, indicating lysogenization. Bottom: a cell is apparently infected by one λ*P*^*-*^ phage (blue dot at 0 min). The cell does not divide, and only minimal expression of gpD-mTurquoise2 is detected, indicating that the phage failed to reach either the lytic or lysogenic decision.(C) Lysogenization frequency of λWT and λ*P*^*-*^. For both phages, the lysogenization frequency increases with MOI. λ*P*^*-*^ has lower lysogenization frequencies at MOI ≤ 3, and reaches a similar level at MOI = 4. At MOI = 1, no lysogenization events (0 of 35 infections) are observed for λ*P*^*-*^. Error bars denote SEM.Scale bars denote 2 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Single-Molecule Characterization of pR Transcription Activity after Phage Infection {#sec2.2}
-----------------------------------------------------------------------------------

Most of the key lysis-lysogeny-determining genes, including *cII* and *Q*, are located on the pR transcript ([Figure 2](#fig2){ref-type="fig"}A). Therefore, to determine the overall expression of cellular decision-controlling regulators, we quantified the level of pR transcription at the single-cell level using smFISH (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc1){ref-type="supplementary-material"} for more details), by targeting the *cII* gene and its neighboring region, as an initial step to uncover the molecular mechanism of the decision-making process. In these experiments, we controlled the MOI by infecting with an API of 0.1--0.2. As the distribution of the number of phage particles per cell follows a Poisson distribution ([@bib52]), the estimated percentages of infected cells (cells with ≥1 infecting phages) at an API of 0.1 and 0.2 were 9.5% and 18.1%, respectively. Correspondingly, the estimated percentages of MOI = 1 infections within infected cells were 95.1% and 90.3%. Indeed, we observed that the percentage of cells showing *cII* signals ranges from 10.8% to 15.2% in multiple experiments ([Figure 2](#fig2){ref-type="fig"}B), indicating that the infection API is within the range of 0.1--0.2. Under these experimental conditions, most infections are at an MOI of 1. This minimized the effect of MOI, an important factor affecting the lysogenization frequency ([@bib23]), and therefore allowed us to focus on the role of DNA replication for cell-fate decisions by one single infecting phage. At 0 min after λWT phage infection, a small fraction of cells displayed one *cII* focus ([Figure 2](#fig2){ref-type="fig"}C), which likely corresponds to one single mRNA or a few mRNAs clustering together. At later time points, i.e., 6 min as shown in [Figure 2](#fig2){ref-type="fig"}D, the *cII* mRNA clusters become larger and brighter, indicating that *cII* mRNA level increases in cells over time. The percentage of cells showing *cII* transcription quickly reaches a plateau within the first 2 min of infection, indicating that gene expression closely follows phage infection ([Figure 2](#fig2){ref-type="fig"}B). To validate our mRNA detection method, we quantified the mRNA numbers from smFISH (see details in [Transparent Methods](#mmc1){ref-type="supplementary-material"} and [Figure S3](#mmc1){ref-type="supplementary-material"}) and then compared the average expression levels with data obtained by qRT-PCR. The data obtained from the two methods were in good agreement ([Figure S4](#mmc1){ref-type="supplementary-material"}). Overall, the average *cII* mRNA level quickly peaked at around 6--12 min after infection, and subsequently dropped ([Figure 2](#fig2){ref-type="fig"}E), reflecting the repression of pR promoter by either CI or Cro ([@bib22], [@bib30]). Moreover, *cII* levels in different cells showed a wide population distribution ([Figure 2](#fig2){ref-type="fig"}F). For example, at 6 min, the number of *cII* molecules per cell has a mean of 38.8 and a coefficient of variation of 0.47.Figure 2Schematic of Lambda Lysis-Lysogeny Decision-Making and the Characterization of *cII* mRNA Expression(A) The pR transcript includes the *cro*, *cII*, *O*, *P*, and *Q* genes. Cro and CI both repress the pR promoter. O and P are required for phage DNA replication. CII activates the expression of CI from the pRE promoter, whereas it represses Q through paQ. Q allows transcription of the lysis and morphogenesis genes from pR′.(B) Percentage of cells showing *cII* expression after infection. Data from multiple experiments were shown. A plateau is reached after 2 min of infection, when samples were taken every 2 min (Exp4). Overall, between 10.8% (Exp3, averaged over 6--40 min) and 15.2% (Exp5, averaged over 6--24 min) of the cells show *cII* expression in multiple experiments, consistent with an API of 0.1--0.2. Error bars denote SEM.(C) Representative images showing cells from the negative and positive samples. Top: cells without phage infection. None of the cells show *cII* signal. Bottom: cells with λWT infection at API = 0.2. Images were taken at 0 min. One cell shows a distinct focus (red). The other two cells do not show foci either because they have not started the mRNA expression, or they are not infected.(D) Representative images showing *cII* mRNA expression at 6 min. *cII* mRNA appeared as clusters instead of punctate foci.(E) Average *cII* levels (calculated as the average of all cells pooled from all 5 experiments) over time after λWT infection. Data from multiple experiments (dots) and the mean (black line) are shown. Only infected cells with *cII* expression were included in the calculation. *cII* expression reaches a peak at around 6--12 min after infection and subsequently drops.(F) Distribution of *cII* mRNA levels at different time points. Combined data from Exp1, Exp3, and Exp5 (as in panels D and E) are shown. The *cII* mRNA distributions at 6 and 12 min are similar and gradually shift to the lower end after 18 min.Scale bars denote 2 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

*cII* Expression Is Robust to Gene Dosage Changes Arising from DNA Replication {#sec2.3}
------------------------------------------------------------------------------

Having validated the smFISH method under our experimental settings, we proceeded to investigate the effect of DNA replication on the expression of transcription factor *cII*. Unexpectedly, λWT and λ*P*^*-*^ displayed similar levels of *cII* mRNA expression on average, especially through the first 18 min ([Figure 3](#fig3){ref-type="fig"}A). As these smFISH experiments were performed in lysogeny broth (LB) medium, where cell lysis typically occurs at ∼60 min and lysogenic decisions are reached within the first 20 min, the data suggest that *cII* expression is not affected by DNA replication in the time window when lysogenic decisions are processed. After 24 min, the *cII* level for λWT remains higher, whereas λ*P*^*-*^ seems to drop more rapidly and reach a lower level ([Figure 3](#fig3){ref-type="fig"}A). The reasons for the difference in *cII* level at the late time points can be complicated as different decisions are reached and different feedback regulations are in place. We therefore focused on the early time points (0--18 min) and asked if *cII* expression dynamics are altered in the absence of DNA replication to result in the decreased lysogenic frequency that we observed through live-cell movies ([Figure 1](#fig1){ref-type="fig"}C) and bulk lysogenic assays ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Surprisingly, we did not observe significant differences in the distribution of *cII* mRNA between λWT and λ*P*^*-*^ either ([Figure 3](#fig3){ref-type="fig"}B).Figure 3Early *cII* Expression Is Not Affected by DNA Replication(A) Average *cII* levels comparing λWT, λ*P*^*-*^, and λ*cro*^*-*^*P*^*-*^ infections. Data from multiple experiments are shown, and solid lines represent the mean of all cells pooled from different experiments. In the first 18 min, λWT and λ*P*^*-*^ have similar *cII* levels. After 24 min of infection, average λWT *cII* level is higher compared with λ*P*^*-*^. Average *cII* expression for λ*cro*^*-*^*P*^*-*^ infection is higher throughout the infection.(B) Distribution of *cII* mRNA levels at 6, 12, and 18 min after infection. λWT and λ*P*^*-*^ have similar *cII* distributions, whereas λ*cro*^*-*^*P*^*-*^ infection shows higher *cII* expression levels.(C) Average DNA level after infection. Fold change is calculated as the ratio of phage DNA to *E. coli* DNA normalized to time 0 and further normalized to the mean of λ*P*^*-*^ and λ*cro*^*-*^*P*^*-*^ data at the corresponding time point. For λWT and λ*cro*^*-*^ infection, phage DNA level increases by 256 ± 7-fold and 29 ± 5-fold, respectively, after 40 min of infection. Error bars denote SEM.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

To rule out the possibility that phage DNA replication simply does not occur until after 18 min, we quantified the phage DNA level using qPCR. As shown in [Figure 3](#fig3){ref-type="fig"}C (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} and [Figure S5](#mmc1){ref-type="supplementary-material"} for more details), the relative number of phage DNA to *E. coli* genome increases by 16.5 ± 5 (mean ± SEM) fold at 18 min after λWT infection, indicating that phages undergo a substantial amount of DNA replication within this time frame. On the contrary, λ*P*^*-*^ infection had no detectable replication, as expected ([Figure 3](#fig3){ref-type="fig"}C). Altogether, our results suggest that *cII* expression is robust to the gene dosage variations resulting from DNA replication during the early infection time window.

Having shown that λ*P*^*-*^ infection leads to the same levels of *cII* mRNA expression during the decision-making time window, we next wanted to confirm that the CII protein concentration in the λ*P*^*-*^ strain is also sufficient for the activation of the pRE promoter. We used a multi-copy plasmid, pRE-*mCherry*, to report the activation of pRE promoter by CII ([@bib22], [@bib52]). This system artificially increases the copy number of pRE promoter without affecting the decision-making of λWT phage ([@bib52]). We used EYFP-labeled fluorescent phages (green dots in [Figures 4](#fig4){ref-type="fig"}A and 4B) to quantify the MOI. We found that at MOI = 1, 62.9% (N = 835) of λ*P*^*-*^ and 50.5% (N = 101) of λWT infections were able to activate this reporter ([Figure 4](#fig4){ref-type="fig"}), further confirming that a single λ*P*^*-*^ DNA is capable of producing a sufficient amount of CII protein to activate the pRE promoter, an essential step in establishing lysogeny. In fact, the percentage activation by λ*P*^*-*^ was slightly higher than that of λWT infections, which might be due to additional effects of DNA replication on the expression of other genes that also affect the decision outcomes.Figure 4Normal pRE Activation without DNA Replication(A) Representative images of lytic and lysogenic events by λWT infections at MOI = 1. Top: expression of gpD-EYFP (green) is observed and the cell lyses at 95 min. Bottom: increase of mCherry (red) expression and normal cell division is observed, indicating a successful lysogenic event.(B) Representative images showing λ*P*^*-*^ infections at MOI = 1. Top: increase in mCherry expression is observed, indicating the activation of pRE promoter. Low levels of gpD-EYFP expression are also detected in the cell. Bottom: only a very low level of gpD-EYFP expression is observed. Division is inhibited, and the cell keeps growing longer without lysing. Same contrast was applied to the images in (A) and (B) at 65 and 95 min. At 0 min, a different contrast if applied to see the green phage particles.(C) Percentages of cells with pRE activation at different MOIs. Both phages show similar levels of pRE activation at different MOIs. Error bars denote SEM.Scale bars denote 2 μm.

*cI* Expression Responds Strongly to Gene Dosage Changes Arising from DNA Replication {#sec2.4}
-------------------------------------------------------------------------------------

So far, our data suggest that the main effect of DNA replication during phage lysogenization is on downstream processes of *cII* expression. To understand why the lack of DNA replication decreases the lysogenic frequency, we next compared *cI* expression in the presence and absence of DNA replication. By simultaneously detecting *cII* and *cI* mRNA, we found that whereas 33.4 ± 1.7% (averaged over time points 24, 36, and 48 min, with N = 152, 126, and 152, respectively) λWT-infected cells show *cI* expression, very few λ*P*^*-*^-infected cells (0, 1, 2, 0, and 0 out of N = 62, 157, 111, 102, and 61 cells at time points 0, 12, 24, 36, and 48 min, respectively) express *cI* mRNA at API ≤ 0.2 ([Figure 5](#fig5){ref-type="fig"}A). Moreover, in those rarely observed *cI*-expressing cells infected by λ*P*^*-*^, the expression level is very low (≤2 *cI* mRNA per cell), confirming a severe deficiency in *cI* expression in the absence of DNA replication.Figure 5Low *cI* Expression without DNA Replication(A) Percentage of infected cells with *cI* expression. After 24 min, 33.4 ± 1.7% (averaged over 24, 36 and 48 min) of λWT infection leads to *cI* expression, which is higher than λ*cro*^*-*^*P*^*-*^. Frequency of *cI* expression in λ*P*^*-*^ infection is very low. Error bars denote SEM.(B) Comparison of average *cI* expression level. Only cells with *cI* expression are included for calculation. *cI* level for λWT peaks at around 12--24 min. λ*cro*^*-*^*P*^*-*^ has delayed *cI* peak time at 40 min with a lower peak level. Error bars denote SEM.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To further dissect the mechanism of lysogenic establishment, we tested a λ*cro*^*-*^*P*^*-*^ double mutant. Due to the absence of the repressor Cro, this double mutant has much higher *cII* mRNA levels compared with λWT ([Figures 3](#fig3){ref-type="fig"}A and 3B). With this mutant, we characterized how a single phage DNA responds to elevated *cII* levels. We found that cells infected by this mutant phage showed *cI* mRNA expression less frequently, despite having higher *cII* levels than the λWT infections ([Figure 5](#fig5){ref-type="fig"}A). The average *cI* expression level for λ*cro*^*-*^*P*^*-*^ is also lower ([Figure 5](#fig5){ref-type="fig"}B), suggesting that this phage cannot effectively carry out the lysogenic decision despite having ample expression of *cII*. Our bulk lysogenization assay also showed that λ*cro*^*-*^*P*^*-*^ does not lysogenize as frequently as λWT ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Altogether, the data suggest that CII is not the only key factor regulating *cI* expression and lysogenic decisions, and that a single phage DNA is generally incompetent at consummating lysogeny. An increase in DNA copy number is important to enable the production of additional *cI* transcripts to boost CI levels.

Cro Negative Feedback Enables *cII* Expression Robustness against Replication-Associated Gene Dosage Variations {#sec2.5}
---------------------------------------------------------------------------------------------------------------

To systematically understand how the viral gene network encodes *cII* robustness to viral DNA replication, we computationally simulated the network behavior in the infection process by adapting a published model ([@bib9]). This model includes the key components of the decision-making network, namely, Cro, CI, and CII and their interactions, as well as DNA replication ([Figures 2](#fig2){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}, [Tables S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}). The goal of the model is to capture the important behaviors of the true network, not to account for all of its known features. This model simulates transcription of pR mRNA, which is then translated into CII and Cro proteins. CII activates the pRE promoter, driving the transcription and translation of the *cI* gene. We phenomenologically modeled the repression of the pR promoter by CI and Cro using Hill functions ([@bib9], [@bib18], [@bib39], [@bib51]). Likewise, we used Hill functions to model the CI activation and Cro repression of pRM promoter. As we focused on the early decision-making phase of infection when CI is not highly expressed, we did not include the CI repression on pRM promoter for simplicity. We also modeled viral DNA replication and its effects on CI, CII, and Cro expression. Lastly, we phenomenologically modeled the repression of CI on DNA replication using a Hill function. The *cII* expression level predicted by this model agreed closely with the experimental data ([Figure 6](#fig6){ref-type="fig"}A), indicating that the interactions in the model were sufficient to capture the robustness of CII levels to DNA replication. We have also built a more complex model where the binding and unbinding reactions of transcription factors to their cognate promoters are simulated in detail. This model has similar performance to the simplified model that we presented above (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}, [Figure S7](#mmc1){ref-type="supplementary-material"}, [Tables S8](#mmc1){ref-type="supplementary-material"} and [S9](#mmc1){ref-type="supplementary-material"} and [Data S1](#mmc2){ref-type="supplementary-material"} for more details), therefore, only the results of the simplified model will be further discussed here.Figure 6Cro Is Important for the Robustness of *cII* Expression to DNA Replication(A) The model prediction of the mean *cII* level in comparison with the experimental data. The model captures the average *cII* expression for λWT, λ*P*^*-*^, and λ*cI*^*-*^. Both experimental quantification and model prediction show that λ*cI*^*-*^ mutant has similar *cII* expression levels to λWT and λ*P*^*-*^ at the early infection period (0--20 min).(B) Model prediction of the relative pR and pRE mRNA levels under different replication rates. Under the model assumptions, pR transcription level shows minimal changes as the replication rate varies between 0- and 1-fold of the original replication rate, whereas the pRE level varies greatly, agreeing with experimental observations.(C) Model prediction of the sensitivity of pR mRNA levels for λ*cro*^*-*^ and λ*cI*^*-*^ mutants. Removing Cro from the model gives rise to pR transcription sensitivity to DNA replication, whereas removing CI does not cause significant changes.(D) Experimental validation of the role of Cro in *cII* expression robustness to DNA replication. In the *cro*^*-*^ background, removing DNA replication (λ*cro*^*-*^*P*^*-*^) causes a decrease of *cII* level at 18 and 24 min.(E) *cII* expression sensitivity to DNA replication. The sensitivity is calculated as the absolute difference in *cII* level between λWT and λ*P*^*-*^ (with Cro) or λ*cro*^*-*^ and λ*cro*^*-*^*P*^*-*^ (without Cro) at each time point divided by the DNA number difference within each group. In the absence of Cro, the *cII* expression sensitivity to DNA replication greatly increases, as shown at 18 and 24 min.See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

We next sought to understand which network features or components give rise to the *cII* expression robustness to DNA replication. Examining this network, we found two network features regulating pR mRNA transcription: the Cro negative feedback regulation and CI negative feedback regulation ([Figure 2](#fig2){ref-type="fig"}A). Negative feedback is a network motif that has been shown to possess properties such as reducing gene expression noise and linearizing gene expression level to the input signal ([@bib6], [@bib29]). To determine whether any of these two negative feedback regulatory links alone is responsible for *cII* mRNA expression robustness, we systematically removed the effect of CI and Cro on pR transcription and DNA replication to generate computational mutants with compromised feedback regulation. To examine the sensitivity of mRNA expression to different rates of DNA replication for the various computational mutants, we first calculated for each time point *t* from 6 to 24 min the average fold change, *F* (*ɛ*, *t*), defined as the ratio of mRNA levels at replication rate *ɛ*⋅*r* (for 0 ≤ *ɛ* ≤ 1) versus mRNA levels at the WT replication rate *r*. Then, we calculated the time-average of this quantity, *F*(ε), to get the sensitivity over all time points. In the WT background, the model successfully predicted the *cII* expression robustness to DNA replication ([Figure 6](#fig6){ref-type="fig"}B). Moreover, CI removal did not compromise the robustness of *cII* expression to a wide range of replication rates ([Figure 6](#fig6){ref-type="fig"}C). On the contrary, removing Cro significantly increases the sensitivity of *cII* expression to DNA replication ([Figure 6](#fig6){ref-type="fig"}C), indicating the importance of Cro for the robustness of *cII* expression to DNA replication.

To validate these theoretical predictions, we then experimentally probed the expression of *cII* in different mutant backgrounds. As expected, *cII* expression was similar among the λ*cI*^*-*^, λ*P*^*-*^, and λWT infections ([Figure 6](#fig6){ref-type="fig"}A), suggesting that CI is not essential for *cII* expression robustness under our experimental settings. We further tested the role of Cro negative feedback by comparing *cII* expression level between λ*cro*^*-*^ and λ*cro*^*-*^*P*^*-*^. As shown in [Figure 6](#fig6){ref-type="fig"}D, λ*cro*^*-*^*P*^*-*^ infection leads to lower *cII* levels at 18 and 24 min compared with λ*cro*^*-*^. As the replication rate of λ*cro*^*-*^ phage is lower compared with λWT, we then calculated the *cII* expression sensitivity as the mean *cII* level change per extra DNA ([Figure 6](#fig6){ref-type="fig"}E), which indicated robustness. Altogether, our data suggest that Cro can overcome the variations of gene dosages to result in *cII* expression robustness. To understand the difference between the contributions of CI and Cro to the *cII* expression robustness, we examined the timing and expression of CI versus Cro. CI is only expressed in cells entering the lysogenic state (33.4% for λWT at MOI = 1, [Figure 5](#fig5){ref-type="fig"}A), whereas Cro is present in all cells. Moreover, by the time DNA replication starts (∼6 min), there is most likely a substantial amount of Cro present already, since Cro is one of the first two genes to be expressed during infection. On the contrary, *cI* expression only starts when CII protein reaches a certain threshold. It is therefore possible that the different contributions of CI and Cro to *cII* expression robustness are due to their difference in the timing and magnitude of expression, yet further experimentation is needed to provide more support.

Discussion {#sec3}
==========

The lysis-lysogeny decision-making of bacteriophage lambda has long served as a paradigm for studying stochastic cell-fate selection, due to the well-established genetic networks involved ([@bib30]). Following decades of studies, researchers have characterized the effects of most genetic components ([@bib14]) and built models to understand this process systematically ([@bib3], [@bib18], [@bib51]). However, due to the limit of resolution in previous experimental approaches, the effect of DNA copy number changes resulting from DNA replication on the decision-making process has been largely neglected, which may have obscured important aspects of this process. Here, we provided more quantitative measurements of their effects on gene expression, decision-making, and the enforcement of the cell-fate decisions.

Gene expression and DNA replication are both partly stochastic processes ([@bib12], [@bib20], [@bib37]), and in the lambda network, DNA replication and the expression of genes, such as Cro, can affect each other. O and P, proteins required for phage DNA replication, are under the control of pR promoter, and their expression is affected by Cro and CI. In addition, replication initiation seems to require active pR transcription ([@bib11], [@bib26]), whereas Cro and CI both repress pR promoter activities. On the other hand, pR transcription goes in the opposite direction of DNA replication, originating from λ*ori* located at the *O* gene region. As head-on collisions between transcription and replication have been shown to slow replication ([@bib27], [@bib34], [@bib45]), pR transcription and phage DNA replication might be constantly affecting each other as well. This dynamic interplay may have interesting impacts on the level of gene expression and DNA replication. Due to the limit of our experimental approaches, we cannot follow the copy number changes of phage DNA simultaneously with the expression of genes. As a result, the exact cellular concentrations of phage DNA and *cII* and *cI* mRNAs at the time of lysogenic establishment are unknown. Future experiments with higher resolutions are needed to allow the examination of the correlations of DNA copy number with cell-fate selection.

Increasing the copy number of promoters can titrate transcription factors and lead to complex dosage response ([@bib25], [@bib41]). Using a simple repression regulatory architecture, researchers have found that at a high transcription factor:promoter ratio, the gene expression response is similar to that of a single isolated copy of the gene ([@bib7]). Networks invariant to gene dosage have also been reported. In *Saccharomyces cerevisiae*, the activity of the galactose signaling network (GAL network) was invariant to the network dosage changes when the gene copy number was halved ([@bib1]). The finding was further generalized by mathematical simulations to conclude that for any N-component network, containing a 2-component subnetwork with an activator, an inhibitor, as well as a 1:1 stoichiometry interaction between the activator and inhibitor is both necessary and sufficient for the network to be dosage compensated ([@bib1], [@bib44]). An alternative mechanism that provides robustness to DNA copy number changes is an incoherent feedforward loop with DNA copy number as its source node ([@bib42]).

Notably, in these studies, the copy number changes are usually introduced through deletion and insertion of genes, or changing the plasmid copy numbers, and it is possible that the effects of dosage variations resulting from DNA replication can be different. In the lambda system, both MOI and DNA replication affect decision-making by affecting the DNA concentration, although the response of *cII* expression to these two factors seems to be different. Experimentation and theoretical modeling have suggested that the difference might be due to Cro. Specifically, increasing the MOI leads to the introduction of more copies of DNA into a cell in which Cro is not present yet. On the contrary, by the time DNA replication starts, Cro has been expressed to a certain level such that negative feedback by Cro counteracts the effect of increasing template number on *cII* expression.

Strategies such as negative feedback are commonly utilized by gene regulatory networks to increase gene expression stability ([@bib6]), or to linearize the input-output response of the genes ([@bib29]). By reducing the gene expression noise, networks can achieve more ordered, "deterministic" outcomes, as reliability is important for many cellular processes. For phage lambda, as a repressor, Cro has been shown to perform multiple important roles in the development of the lytic pathway ([@bib10], [@bib19], [@bib36], [@bib48]). Interestingly, by artificially inserting Cro onto the *E. coli* chromosome and placing Cro under the control of pR with one single operator binding site, oR1 (as opposed to three: oR1, oR2, and oR3, in the native lambda genome), researchers observed oscillations of Cro expression, synchronized to the cell cycle and the associated gene copy changes ([@bib15]). However, the period of these oscillations were several fold longer than the time frame of lambda phage decision-making right after infection. Here, our work suggests that Cro-mediated negative feedback can stabilize the activity of the pR promoter against DNA copy number variations resulting from DNA replication, thus creating conditions wherein the early decision-making process is not affected by DNA replication. Since Cro plays two major roles in the network, both to repress pR promoter activity and to modulate the rate of DNA replication, these two functions may seem convoluted in providing *cII* expression robustness. However, it is hard to decouple the two roles of Cro both experimentally and theoretically due to the complex interplay between Cro and DNA replication as discussed. Future work to elucidate the mechanism of regulation on DNA replication by Cro as well as the development of mutants to separate the two functions of Cro will be of great interest.

Whether or not transcription factor expression robustness to network dosage changes confers any evolutionary advantages to the lambda decision-making circuit remains unknown. Due to the different physiological state or growth phase of the host cell, the levels of DNA replication may be different in different cells. The resource level, i.e., the available DNA polymerase, may fluctuate in response to different environmental stimuli to result in changes in the rate of DNA replication. To address these potential changes, lambda seems to adapt by allowing its effector (*cI*) expression to respond to the DNA copy number changes rather than altering the actual decision-making (*cII* expression) behavior. Recent studies showed that dosage-compensating networks can act as a noise reduction module to reduce the effects of extrinsic noise on the network output ([@bib31]). In the lambda system, the behavior of the decision-making circuit in response to fluctuations in different cellular factors remain unknown.

Overall, our study has shown that the lambda decision-making process is composed of an intricate network where both MOI changes and replicating DNA can significantly affect the outcomes. However, the lambda network is far more complicated than what we described here. CIII is also an important factor for lysogenic establishment by promoting CII stability ([@bib16], [@bib17]), and its expression might also be affected by DNA replication, yet it is neglected in our models for simplicity. The anti-terminator N is critical for phage development by allowing the transcription to go beyond N and Cro production at the immediately early stage, and possibly regulates the temporal progression of gene expression as well as decision-making ([@bib30]). On the other hand, the fate-determining genes on the pR transcript, although promoted from the same promoter, are in fact separated by several terminators, tR1--4 ([@bib8], [@bib30]). Although N can allow transcription to go past those terminators, the efficiencies may vary ([@bib13]). This adds another layer of regulation, and a more systematic examination of gene expression is required to fully understand the lambda decision-making network.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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